Update from Aisha Akhtar, MD Colorectal cancer is not only the third most commonly diagnosed cancer, but also the third leading cause of death in the U.S. among men andLEARN MORE
As you know, drug shortages can occur for many reasons, including manufacturing and quality problems, delays and discontinuations. Our goal is to keep you informed about any issues we areLEARN MORE
Dear HonorHealth Medical Staff member, You will find the current network-wide guidelines for required perioperative testing at this link. This was extensively reviewed before implementation and adheres to recommended bestLEARN MORE
Catching lung cancer early and treating it quickly leads to the best hope of beating the disease. Offering your patients a lung cancer screening offers hope for early detection, whenLEARN MORE
What is happening: VTEstimator, the application used to recommend VTE chemoprophylaxis for Total Hip and Total Knee patients will be eliminated at HonorHealth on Sunday, Nov. 13, 2022. Why isLEARN MORE
The oral antiviral TPOXX (tecovirimat) is available under an expanded access, Investigational New Drug protocol for the treatment of acute Monkeypox infection. Under this protocol, it is not available inLEARN MORE
Platelets return to Level 1 inventory status; group O inventories remain constrained at Level 2. Please review this document for more details about inventory levels.
Albumin 5% 250mL and 500mL presentations are critically short secondary to manufacturing delays. The duration of the shortage is unknown and earliest estimates on resolution are mid-late October 2022. HonorHealthLEARN MORE
Based on the Planned Parenthood of Tucson v. Brnovich ruling on Friday, Sept. 23, HonorHealth’s policy regarding termination of pregnancy has been updated in PolicyStat. VIEW THE POLICY
